5min chapter

Breakpoints cover image

#35 – Oral Beta-Lactams, Are We Serious?

Breakpoints

CHAPTER

How to Use Oral Beta Lactams to Improve Treatment Decisions

Jesse: I have a couple of ideas, research ideas that maybe some people can jump on. One would be pharmacokinetic models for a wider variety of patients and doses of these drugs. The other one is correlating the susceptibility that we receive to the oral cephalosporins that we'd actually be using. We talked about how you might just get a cepHalosene susceptibility or a cep Halosene MIC. And then we're extrapolating that to cep halosene or extrapolating it to cepyroxine. So those are my pearls. Thank you, Jesse, for all these wonderful ideas on research and giving inspiring some

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode